The Department of Health and Social Care have banned the use of puberty blockers in the UK for those under 18 indefinitely.

The companies plan to integrate and pilot their combined technologies to gain insight into improving cardiovascular care.

A freeze placed this year on their use to treat gender dysphoria will remain in place for young people under 18, except in ...

The ban will prevent prescribing medications that can suppress or pause puberty in children with gender dysphoria ...

Ban does not apply to those already receiving drugs for gender dysphoria, treatment of children with rarely diagnosed ...

Chimerix’s dordaviprone shows potential for glioma treatment with a possible FDA approval by 2025. Read why CMRX stock is a ...

The decision comes as the Supreme Court hears oral arguments for U.S v. Jonathan Skrmetti, a case which will determine the ...

Wednesday’s announcement that the ban on sale and supply of puberty blockers through private prescriptions for under-18s is ...

In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.

Health Secretary Wes Streeting announced an indefinite ban on puberty blockers for under-18s with gender dysphoria (Ben ...

Labour MPs hit out at the policy, with Kate Osborne saying the move ‘removes the clinical expertise from medical decision ...